IBDEI1CT ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23012,2)
 ;;=^5003066
 ;;^UTILITY(U,$J,358.3,23013,0)
 ;;=G30.0^^87^988^1
 ;;^UTILITY(U,$J,358.3,23013,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23013,1,3,0)
 ;;=3^Alzheimer's Disease w/ Early Onset
 ;;^UTILITY(U,$J,358.3,23013,1,4,0)
 ;;=4^G30.0
 ;;^UTILITY(U,$J,358.3,23013,2)
 ;;=^5003805
 ;;^UTILITY(U,$J,358.3,23014,0)
 ;;=G30.8^^87^988^3
 ;;^UTILITY(U,$J,358.3,23014,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23014,1,3,0)
 ;;=3^Alzheimer's Disease,Other
 ;;^UTILITY(U,$J,358.3,23014,1,4,0)
 ;;=4^G30.8
 ;;^UTILITY(U,$J,358.3,23014,2)
 ;;=^5003807
 ;;^UTILITY(U,$J,358.3,23015,0)
 ;;=G30.1^^87^988^2
 ;;^UTILITY(U,$J,358.3,23015,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23015,1,3,0)
 ;;=3^Alzheimer's Disease w/ Late Onset
 ;;^UTILITY(U,$J,358.3,23015,1,4,0)
 ;;=4^G30.1
 ;;^UTILITY(U,$J,358.3,23015,2)
 ;;=^5003806
 ;;^UTILITY(U,$J,358.3,23016,0)
 ;;=G30.9^^87^988^4
 ;;^UTILITY(U,$J,358.3,23016,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23016,1,3,0)
 ;;=3^Alzheimer's Disease,Unspec
 ;;^UTILITY(U,$J,358.3,23016,1,4,0)
 ;;=4^G30.9
 ;;^UTILITY(U,$J,358.3,23016,2)
 ;;=^5003808
 ;;^UTILITY(U,$J,358.3,23017,0)
 ;;=G21.4^^87^988^45
 ;;^UTILITY(U,$J,358.3,23017,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23017,1,3,0)
 ;;=3^Vascular Parkinsonism
 ;;^UTILITY(U,$J,358.3,23017,1,4,0)
 ;;=4^G21.4
 ;;^UTILITY(U,$J,358.3,23017,2)
 ;;=^5003776
 ;;^UTILITY(U,$J,358.3,23018,0)
 ;;=G20.^^87^988^34
 ;;^UTILITY(U,$J,358.3,23018,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23018,1,3,0)
 ;;=3^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,23018,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,23018,2)
 ;;=^5003770
 ;;^UTILITY(U,$J,358.3,23019,0)
 ;;=G25.0^^87^988^15
 ;;^UTILITY(U,$J,358.3,23019,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23019,1,3,0)
 ;;=3^Essential Tremor
 ;;^UTILITY(U,$J,358.3,23019,1,4,0)
 ;;=4^G25.0
 ;;^UTILITY(U,$J,358.3,23019,2)
 ;;=^5003791
 ;;^UTILITY(U,$J,358.3,23020,0)
 ;;=G25.2^^87^988^44
 ;;^UTILITY(U,$J,358.3,23020,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23020,1,3,0)
 ;;=3^Tremor,Other Spec Forms
 ;;^UTILITY(U,$J,358.3,23020,1,4,0)
 ;;=4^G25.2
 ;;^UTILITY(U,$J,358.3,23020,2)
 ;;=^5003793
 ;;^UTILITY(U,$J,358.3,23021,0)
 ;;=G25.1^^87^988^43
 ;;^UTILITY(U,$J,358.3,23021,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23021,1,3,0)
 ;;=3^Tremor,Drug-Induced
 ;;^UTILITY(U,$J,358.3,23021,1,4,0)
 ;;=4^G25.1
 ;;^UTILITY(U,$J,358.3,23021,2)
 ;;=^5003792
 ;;^UTILITY(U,$J,358.3,23022,0)
 ;;=G25.81^^87^988^38
 ;;^UTILITY(U,$J,358.3,23022,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23022,1,3,0)
 ;;=3^Restless Legs Syndrome
 ;;^UTILITY(U,$J,358.3,23022,1,4,0)
 ;;=4^G25.81
 ;;^UTILITY(U,$J,358.3,23022,2)
 ;;=^5003801
 ;;^UTILITY(U,$J,358.3,23023,0)
 ;;=G35.^^87^988^31
 ;;^UTILITY(U,$J,358.3,23023,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23023,1,3,0)
 ;;=3^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,23023,1,4,0)
 ;;=4^G35.
 ;;^UTILITY(U,$J,358.3,23023,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,23024,0)
 ;;=G40.901^^87^988^13
 ;;^UTILITY(U,$J,358.3,23024,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23024,1,3,0)
 ;;=3^Epilepsy,Not Intractable w/ Status Epilepticus,Unspec
 ;;^UTILITY(U,$J,358.3,23024,1,4,0)
 ;;=4^G40.901
 ;;^UTILITY(U,$J,358.3,23024,2)
 ;;=^5003864
 ;;^UTILITY(U,$J,358.3,23025,0)
 ;;=G40.909^^87^988^14
 ;;^UTILITY(U,$J,358.3,23025,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23025,1,3,0)
 ;;=3^Epilepsy,Not Intractable w/o Status Epilepticus,Unspec
 ;;^UTILITY(U,$J,358.3,23025,1,4,0)
 ;;=4^G40.909
 ;;^UTILITY(U,$J,358.3,23025,2)
 ;;=^5003865
 ;;^UTILITY(U,$J,358.3,23026,0)
 ;;=G43.809^^87^988^28
